1
/
of
0
FDA Medical Review for Tafinlar + Mekinist Approval – Accelerated approval on June 22, 2022, NDA 202806/S-022.
FDA Medical Review for Tafinlar + Mekinist Approval – Accelerated approval on June 22, 2022, NDA 202806/S-022.
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
Original Request: I would like to receive the FDA medical review for the drug approval of Tafinlar + Mekinist, which received accelerated approval on June 22, 2022. The NDA number corresponding to the drug combination approval is NDA 202806/S-022.
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details